1st Feb 2016 14:16
LONDON (Alliance News) - TyraTech Inc said Chairman Alan Reade bought 250,000 shares at 2.699 pence per share on Monday.
Following this transaction, Reade now holds 14 million shares, which represents a 3.83% stake in the life sciences company.
TyraTech said Monday it expects to report a net loss in line with expectations for 2015, and "marginally" lower revenue than expected.
The maker of head lice treatment Vamousse attributed the revenue miss to "difficulties in budgeting the timing of revenues arising from the on-boarding process of multiple new retailers."
Shares were down 5.5% at 2.60p Monday.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Tyratech